ReviewPoultry science2026
Nanotechnology-Enabled Approaches in Poultry Coccidiosis Management: Advances, Challenges, and Future Perspectives.
Review in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian coccidiosis, a disease resulting from infection by various Eimeria species, is a major constraint to global poultry production, causing considerable economic losses and affecting animal performance. Traditional approaches to coccidiosis control, such as anticoccidials and live vaccines, face limitations in their use owing to resistance, safety concerns, and species-specific immunity. In this regard, subunit, DNA, and multi-epitope vaccines have been tested against coccidiosis, but their efficacy is hindered by the instability of the vaccine antigens and a lack of cross-protection. However, recent advances in nanotechnology may provide a solution to the limitations associated with traditional approaches to coccidiosis control. For instance, nanoparticles may improve vaccine efficacy by stabilizing vaccine antigens, facilitating their delivery, and modulating immune responses. Furthermore, various nanoparticle therapeutics, such as plant-based and metal-based nanoparticles, and nano-encapsulated anticoccidials, may also reduce oocyst shedding and improve gut health and antioxidant status. Although this is a positive step in coccidiosis control, there are many issues that need to be resolved. This review provides a critical analysis of recent advances in various aspects of nanotechnology-based approaches to coccidiosis control, their potential, and research gaps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.